347 related articles for article (PubMed ID: 20615160)
1. Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease.
Kapetanovic MC; Lindqvist E; Simonsson M; Geborek P; Saxne T; Eberhardt K
Scand J Rheumatol; 2010; 39(5):353-9. PubMed ID: 20615160
[TBL] [Abstract][Full Text] [Related]
2. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.
Wållberg-Jonsson S; Johansson H; Ohman ML; Rantapää-Dahlqvist S
J Rheumatol; 1999 Dec; 26(12):2562-71. PubMed ID: 10606363
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular death in rheumatoid arthritis: a population-based study.
Maradit-Kremers H; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
Arthritis Rheum; 2005 Mar; 52(3):722-32. PubMed ID: 15751097
[TBL] [Abstract][Full Text] [Related]
4. Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s.
Kapetanovic MC; Lindqvist E; Geborek P; Saxne T; Eberhard K
Scand J Rheumatol; 2011 Nov; 40(6):433-8. PubMed ID: 21619489
[TBL] [Abstract][Full Text] [Related]
5. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study.
Peters MJ; van Halm VP; Voskuyl AE; Smulders YM; Boers M; Lems WF; Visser M; Stehouwer CD; Dekker JM; Nijpels G; Heine R; Dijkmans BA; Nurmohamed MT
Arthritis Rheum; 2009 Nov; 61(11):1571-9. PubMed ID: 19877093
[TBL] [Abstract][Full Text] [Related]
6. Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: a population-based study.
De Vera MA; Choi H; Abrahamowicz M; Kopec J; Lacaille D
Arthritis Care Res (Hoboken); 2012 Jun; 64(6):809-16. PubMed ID: 22467274
[TBL] [Abstract][Full Text] [Related]
7. Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians.
Jacobsson LT; Turesson C; Hanson RL; Pillemer S; Sievers ML; Pettitt DJ; Bennett PH; Knowler WC
Arthritis Rheum; 2001 May; 44(5):1170-6. PubMed ID: 11352251
[TBL] [Abstract][Full Text] [Related]
8. Comorbidity in arthritis.
Gabriel SE; Crowson CS; O'Fallon WM
J Rheumatol; 1999 Nov; 26(11):2475-9. PubMed ID: 10555912
[TBL] [Abstract][Full Text] [Related]
9. Association of mortality with disease severity in rheumatoid arthritis, independent of comorbidity.
Navarro-Cano G; Del Rincón I; Pogosian S; Roldán JF; Escalante A
Arthritis Rheum; 2003 Sep; 48(9):2425-33. PubMed ID: 13130461
[TBL] [Abstract][Full Text] [Related]
10. Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists.
Greenberg JD; Bingham CO; Abramson SB; Reed G; Sebaldt RJ; Kremer J
Arthritis Rheum; 2005 Feb; 53(1):12-7. PubMed ID: 15696570
[TBL] [Abstract][Full Text] [Related]
11. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.
van Halm VP; Nurmohamed MT; Twisk JW; Dijkmans BA; Voskuyl AE
Arthritis Res Ther; 2006; 8(5):R151. PubMed ID: 16984661
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden.
Wallberg-Jonsson S; Ohman ML; Dahlqvist SR
J Rheumatol; 1997 Mar; 24(3):445-51. PubMed ID: 9058647
[TBL] [Abstract][Full Text] [Related]
13. Prediction of mortality in rheumatoid arthritis based on disease activity markers.
Book C; Saxne T; Jacobsson LT
J Rheumatol; 2005 Mar; 32(3):430-4. PubMed ID: 15742433
[TBL] [Abstract][Full Text] [Related]
14. Depression increases risk of incident myocardial infarction among Veterans Administration patients with rheumatoid arthritis.
Scherrer JF; Virgo KS; Zeringue A; Bucholz KK; Jacob T; Johnson RG; True WR; Carney RM; Freedland KE; Xian H; Caplan L; McDonald J; Eisen SA
Gen Hosp Psychiatry; 2009; 31(4):353-9. PubMed ID: 19555796
[TBL] [Abstract][Full Text] [Related]
15. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.
Jacobsson LT; Turesson C; Gülfe A; Kapetanovic MC; Petersson IF; Saxne T; Geborek P
J Rheumatol; 2005 Jul; 32(7):1213-8. PubMed ID: 15996054
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis.
Panoulas VF; Douglas KM; Milionis HJ; Stavropoulos-Kalinglou A; Nightingale P; Kita MD; Tselios AL; Metsios GS; Elisaf MS; Kitas GD
Rheumatology (Oxford); 2007 Sep; 46(9):1477-82. PubMed ID: 17704521
[TBL] [Abstract][Full Text] [Related]
17. Rheumatoid arthritis is associated with a high prevalence of hypothyroidism that amplifies its cardiovascular risk.
Raterman HG; van Halm VP; Voskuyl AE; Simsek S; Dijkmans BA; Nurmohamed MT
Ann Rheum Dis; 2008 Feb; 67(2):229-32. PubMed ID: 17557891
[TBL] [Abstract][Full Text] [Related]
18. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort.
Goodson NJ; Symmons DP; Scott DG; Bunn D; Lunt M; Silman AJ
Arthritis Rheum; 2005 Aug; 52(8):2293-9. PubMed ID: 16052597
[TBL] [Abstract][Full Text] [Related]
19. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
Yung KC; Piccirillo JF
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
